Midgard Science
NA

Nitto Avecia

Milford, MA, United States avecia.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Nitto Avecia develops and manufactures oligonucleotide therapeutics for pharmaceutical companies, from preclinical work through commercial supply. It operates facilities in Milford, Massachusetts, and Cincinnati, Ohio, serving customers with development, manufacturing, analytical, and quality support.

Services

  • Preclinical Manufacturing

    Provides custom preclinical oligonucleotide manufacturing through the OliGrow® service for non-cGMP applications.

  • Analytical Development

    Develops, qualifies, and validates analytical methods for raw materials, intermediates, and final product, including support for ICH stability studies.

  • Process Development

    Develops and validates oligonucleotide processes and supports onboarding risk assessments, scale-up, specification development, and raw material qualification.

  • Drug Substance Manufacturing

    Manufactures oligonucleotide drug substance from preclinical quantities to commercial supply.

  • Process Performance Qualification

    Develops and executes PPQ programs for oligonucleotide manufacturing.

  • Quality Control/Stability

    Provides study design, comprehensive testing services, and sample storage conditions for quality control and stability work.

Capabilities

Assays and studies
  • Oligonucleotides
  • Analytical development
  • Process development
  • Stability studies
  • CRISPR
  • Analytical method development
8 more
  • Method transfer
  • Method validation
  • Impurity testing
  • Sequencing
  • Environmental monitoring
  • Raw material analysis
  • In-process analysis
  • Final product analysis
Scale and capacity
  • Batch sizes from 100 mg to 25 g
  • Batches from a few mmol up to 1600 mmol
  • First 50 mg of preclinical material
  • Hundreds of kilograms in commercial supply
  • Multiple cGMP manufacturing trains
  • ISO8-qualified, HEPA-filtered manufacturing suites

Instruments and platforms

  • LC-ESI-MS/MS
  • HRAMS

Modalities and species

Modalities
  • Oligonucleotide
  • Gene editing

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    As listed: GMP-compliant; cGMP requirements of 21 CFR Part 210 and

  • FDA registrationSelf-reported

Details

Type
CRDMO
Address
125 Fortune Boulevard Milford, MA 01757
Sites
Cincinnati, United States
Serves
Global

Public records

FDA drug establishment registration
3000215431 · API MANUFACTURE source

Similar labs